Both psoriasis and metabolic syndrome (MetS) are characterised by an inflammatory T cell-mediated process, with over-expression of pro-inflammatory cytokines, tumour necrosis factor (TNF)-a, and interleukin (IL)-6 [3]. Here, IL6 is linked to psoriasis.